A new study published in the Journal of the American College of Cardiology shows that Inclisiran, a twice-yearly injection, can lower LDL cholesterol by nearly 50% in people not taking statins. The treatment also reduced other harmful fats and was well tolerated, offering a promising option for those seeking alternatives to daily pills.